{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:24:04Z","timestamp":1790076244619,"version":"4.0.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Stenotrophomonas maltophilia<\/jats:italic> (SMA) is present in hospital environments and has been one of the pathogens that cause nosocomial contamination and infections. To investigate the occurrence of <jats:italic>Stenotrophomonas maltophilia<\/jats:italic> (SMA) in bronchoscope lavage fluid (BALF) among 25 cases treated in the Division of Infection and to trace the contamination source and transmission route.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>25 cases of SMA positive BALF occurring from May 11 to August 10, 2018 were tested for drug sensitivity. Environmental hygiene conditions were investigated to identify the source of contamination and the route of transmission.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>BALF associated SMA was in all cases sensitive to minocycline, levofloxacin and chloramphenicol and resistant to ceftazidime and imipenem. 92.3% of samples were sensitivity to compound sulfamethoxazole. Investigation of environmental hygiene parameters revealed SMA growing on the inner wall of the fiberoptic bronchoscope as a likely source of contamination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Incomplete cleaning and sterilization of the fiberoptic bronchoscope led to SMA nosocomial contamination. Strict sterilization procedures are required to prevent and control nosocomial contamination.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-019-4670-3","type":"journal-article","created":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T10:02:43Z","timestamp":1576922563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["An investigation of Stenotrophomonas maltophilia-positive culture caused by fiberoptic bronchoscope contamination"],"prefix":"10.1186","volume":"19","author":[{"given":"Bende","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-9205","authenticated-orcid":false,"given":"Shenglan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,21]]},"reference":[{"issue":"2","key":"4670_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jhin.2008.05.020","volume":"70","author":"JI Paez","year":"2008","unstructured":"Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect. 2008;70(2):101\u20138.","journal-title":"J Hosp Infect"},{"issue":"3","key":"4670_CR2","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1099\/00207713-43-3-606","volume":"43","author":"NJ Palleroni","year":"1993","unstructured":"Palleroni NJ, Bradbury JF. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) swings et al. 1983. Int J Syst Bacteriol. 1993;43(3):606\u20139.","journal-title":"Int J Syst Bacteriol"},{"issue":"9","key":"4670_CR3","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s10096-014-2101-3","volume":"33","author":"JW Betts","year":"2014","unstructured":"Betts JW, Phee LM, Woodford N, Wareham DW. Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2014;33(9):1565\u201372.","journal-title":"Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol"},{"issue":"3","key":"4670_CR4","first-page":"193","volume":"18","author":"V Savini","year":"2010","unstructured":"Savini V, Catavitello C, D'Aloisio M, Balbinot A, Astolfi D, Masciarelli G, Pompilio A, Di Bonaventura G, D'Antonio D. Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis. Infez Med. 2010;18(3):193\u20137.","journal-title":"Infez Med"},{"issue":"1","key":"4670_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1590\/S0036-36342011000100009","volume":"53","author":"S Beltran Silva","year":"2011","unstructured":"Beltran Silva S, Cervantes Apolinar Y, Cherry JD, Conde Gonzalez C, Gentile A, Gomez Altamirano CM, Hernandez Porras M, Huerta Garcia G, Macias Parra M, Martinez Aguilar G, et al. Consensus on the clinical and microbiologic diagnosis of Bordetella pertussis, and infection prevention. Expert group on pertussis vaccination. Salud publica de Mex. 2011;53(1):57\u201365.","journal-title":"Salud publica de Mex"},{"issue":"7","key":"4670_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.4103\/ijccm.IJCCM_442_17","volume":"22","author":"P Gupta","year":"2018","unstructured":"Gupta P, Kale P, Khillan V. Resurgence of global opportunistic multidrug-resistant Stenotrophomonas maltophilia. Indian J Crit Care Med. 2018;22(7):503\u20138.","journal-title":"Indian J Crit Care Med"},{"issue":"3","key":"4670_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0732-8893(02)00443-1","volume":"44","author":"EJ Giamarellos-Bourboulis","year":"2002","unstructured":"Giamarellos-Bourboulis EJ, Karnesis L, Giamarellou H. Synergy of colistin with rifampin and trimethoprim\/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia. Diagn Microbiol Infect Dis. 2002;44(3):259\u201363.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"4670_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijantimicag.2009.08.011","volume":"35","author":"CM Drapeau","year":"2010","unstructured":"Drapeau CM, Grilli E, Petrosillo N. Rifampicin combined regimens for gram-negative infections: data from the literature. Int J Antimicrob Agents. 2010;35(1):39\u201344.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"4670_CR9","first-page":"204","volume":"39","author":"B Passerini de Rossi","year":"2007","unstructured":"Passerini de Rossi B, Calenda M, Vay C, Franco M. Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections. Rev Argent Microbiol. 2007;39(4):204\u201312.","journal-title":"Rev Argent Microbiol"},{"issue":"4","key":"4670_CR10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.5604\/01.3001.0010.6996","volume":"66","author":"M Biocanin","year":"2017","unstructured":"Biocanin M, Madi H, Vasiljevic Z, Kojic M, Jovcic B, Lozo J. Temperature, pH and trimethoprim-Sulfamethoxazole are potent inhibitors of biofilm formation by Stenotrophomonas maltophilia clinical isolates. Pol J Microbiol. 2017;66(4):433\u20138.","journal-title":"Pol J Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4670-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4670-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4670-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,20]],"date-time":"2020-12-20T00:11:33Z","timestamp":1608423093000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4670-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4670"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4670-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"26 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the First People\u2019s Hospital of Jiangxi District. Patients provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1072"}}